Patents by Inventor Patricia Underwood

Patricia Underwood has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Two phase bioactive formulations of bis-quaternary pyridinium oxime sulfonate salts
    Patent number: 8722706
    Abstract: The present invention relates to two phase systems of a bioactive ingredient in particle form that has limited or no solubility in a liquid medium, which provides stability to the bioactive ingredient that is similar to the bioactive ingredient when in the solid state. The bioactive ingredient may be capable of therapeutically treating for the presence of a cholinesterase inhibitor. The bio active ingredient comprises 1,1?-methlyenebis[4-[(hydroxyimino)methyl]-pyridinium]dimethanesulfonate.
    Type: Grant
    Filed: August 15, 2008
    Date of Patent: May 13, 2014
    Assignee: Southwest Research Institute
    Inventors: Hong Dixon, Joseph A McDonough, Larry Allen Cabell, Patricia Underwood
  • TWO PHASE BIOACTIVE FORMULATIONS
    Publication number: 20100040692
    Abstract: The present invention relates to two-phase systems of a bioactive ingredient in particle form that has limited or no solubility in a liquid medium, which provides stability to the active ingredient that is similar to the active ingredient when in the solid state. The active ingredient may be capable of therapeutically treating for the presence of a cholinesterase inhibitor.
    Type: Application
    Filed: August 15, 2008
    Publication date: February 18, 2010
    Applicant: SOUTHWEST RESEARCH INSTITUTE
    Inventors: Hong Dixon, Joseph A. McDonough, Larry Allen Cabell, Patricia Underwood
  • Monoclonal antibodies directed against vitronectin and fibronectin, and uses thereof
    Patent number: 5389518
    Abstract: The present invention provides monoclonal antibodies directed against specific domains of fibronectin and vitronectin. These monoclonals may be used in the production of the biomaterial and devices for use in in vitro cell culture. The present invention also provides an efficient method for extracting vitronectin from bovine serum or plasma using monoclonal antibodies and methods for analyzing biological samples for the presence of adhesive glycoproteins or fragments thereof.
    Type: Grant
    Filed: August 1, 1994
    Date of Patent: February 14, 1995
    Assignee: Commonwealth Scientific and Industrial Research Organisation
    Inventors: John G. Steele, Patricia A. Underwood